Richard A. Slayden

Richard A. Slayden

Auto-generated profile, based on publicly available information

Richard A. Slayden

Mycobacteria Research Laboratories, Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1998 in Progress in Lipid Research
Verified
Journal Article
Open access
CIClifton Earl Barry, III
Clifton Earl Barry, III
RLRichard E. Lee
Richard E. Lee
KMKhisimusi Mdluli
Khisimusi Mdluli
ASAndrea E Sampson
Andrea E Sampson
BSBenjamin G Schroeder
Benjamin G Schroeder
YYYing Yuan
Ying Yuan

5 June 1998 in Science
Verified
Journal Article
Closed access
PDF file
KMKhisimuzi Mdluli
Khisimuzi Mdluli
RSRichard A. Slayden
Richard A. Slayden
YZYaQi Zhu
YaQi Zhu
SRSrinivas Ramaswamy
Srinivas Ramaswamy
XPXi Pan
Xi Pan
CIClifton Earl Barry, III
Clifton Earl Barry, III
Although isoniazid (isonicotinic acid hydrazide, INH) is widely used for the treatment of tuberculosis, its molecular target has remained elusive. In response to INH treatment, saturated hexacosanoic acid (C26:0) accumulated on a 12-kilodalton acyl carrier protein (AcpM) that normally carried mycolic acid precursors as long as C50. A protein species purified from INH-treated Mycobacterium tuberculosis was shown to consist of a covalent complex of INH, AcpM, and a β-ketoacyl acyl carrier protein synthase, KasA. Amino acid–altering mutations in the KasA protein were identified in INH-resistant patient isolates that lacked other mutations associated with resistance to this drug.

1 November 1995 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
KMK Mikusová
K Mikusová
RSR A Slayden
R A Slayden
GBGurdyal S. Besra
Gurdyal S. Besra
PBP J Brennan
P J Brennan
The effect of ethambutol (EMB) is primarily on polymerization steps in the biosynthesis of the arabinan component of cell wall arabinogalactan (AG) of Mycobacterium smegmatis. Inhibition of the synthesis of the arabinan of lipoarabinomannan (LAM) occurred later, and thus in the cases of AG and LAM, the polymerization of D-arabinofuranose apparently involves separate pathways. While the synthesis of these arabinans was normal in an EMB-resistant isogeneic strain, the addition of EMB to the resistant strain resulted in partial inhibition of the synthesis of the arabinan of LAM and the emergence of a novel, truncated form of LAM, indicating partial susceptibility of the resistant gene(s) and providing a new intermediate in the LAM biosynthetic sequence. A consequence of inhibition of AG arabinan biosynthesis is the lack of new sites for mycolate attachment and thus the channeling of mycolate residues into a variety of free lipids which then accumulate. The primary biochemical effects of EMB can be explained by postulating separate AG and LAM pathways catalyzed by a variety of extramembranous arabinosyl transferases with various degrees of sensitivity to EMB.

1 February 2006 in ACS Chemical Biology
Verified
Journal Article
Closed access
TSTodd J. Sullivan
Todd J. Sullivan
JTJames J. Truglio
James J. Truglio
MBMelissa E. Boyne
Melissa E. Boyne
PNPolina Novichenok
Polina Novichenok
XZXujie Zhang
Xujie Zhang
PTPeter J. Tonge
Peter J. Tonge

22 January 2003 in Journal of Combinatorial Chemistry
Verified
Journal Article
Closed access
RLRichard E. Lee
Richard E. Lee
MPMarina Protopopova
Marina Protopopova
ECEmma Crooks
Emma Crooks
RSRichard A. Slayden
Richard A. Slayden
MTMarianne Terrot
Marianne Terrot
CIClifton Earl Barry, III
Clifton Earl Barry, III

2 December 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KKKunal Kumar
Kunal Kumar
DADivya Awasthi
Divya Awasthi
SLSeung-Yub Lee
Seung-Yub Lee
IZIlaria Zanardi
Ilaria Zanardi
BRBela Ruzsicska
Bela Ruzsicska
IOIwao Ojima
Iwao Ojima